TOKYO -- SoftBank Group on Wednesday said it established a subsidiary to offer saliva-based coronavirus tests, as Japan continues to grapple with the spread of COVID-19.
The new company, Coronavirus Inspection Center Corp., aims to offer "low cost and high frequency" saliva-based polymerase chain reaction tests, SoftBank said. With the cooperation of the National Center for Global Health and Medicine, it will begin testing employees as well as its baseball team players.
